Blog

  • Curana Health: Revolutionizing Care Delivery in Senior Living Communities through a Value-Based Model

    The whole is greater than the sum of its parts. -Aristotle For more than four decades, NEA has had the privilege of investing in ground-breaking companies, technologies, and business models that have the power to change the trajectory of an industry. Sprinkled among our hundreds of investments are the rare opportunities to not only partner with companies but help form them—Curana Health is one of these stories. Curana’s mission is to improve the health, happiness, and dignity of senior…

  • It’s Time to Prioritize Menopause: Our Investment in Evernow

    An estimated 50-60 million women in the United States are currently experiencing menopause with more than 2 million additional women joining this group every year. Still, despite the global size of the female population and the inevitability of the menopause process, menopause is an area that has remained severely underserved in terms of research, resources, and patient-centric care. Evernow is out to change this. Powered by science-based and tech-enabled solutions, Evernow’s mission is to…

  • Waymark: Transforming Value-Based Care to Empower the Patients Who Need It Most

    Millions of Americans rely on government-funded Medicaid programs to provide them with access to healthcare. The growth of this already massive population—composed of eligible low-income adults, children, pregnant women, elderly adults, and people with disabilities—has accelerated over the course of the COVID-19 pandemic, with one in four Americans relying on Medicaid for coverage. Still, despite Medicaid being the largest source of health coverage in the country, access to quality care and…

  • Making Clinical Trials Boring: Our Investment in Slope.io

    Clinical trials improve patient health and save lives. Without clinical trials, it would be impossible to safely advance treatments for disease, discover novel therapies, expand diagnostic capabilities, explore methods for early detection, analyze patient data, and develop guidelines for effective treatment. There’s a reason why the National Comprehensive Cancer Network (“NCCN”) recommends that the best management of any patient with cancer is in a clinical trial. As of September 2021 there…

  • “Adversity and diversity are gifts…”

    NEA's Q&A series is focused on the company building journey and the impactful work of leaders across NEA’s portfolio. Our goal is to shed light on unique perspectives, guiding principles, defining moments, and lessons learned. Responses have been lightly edited for clarity and length. What led you to join Nkarta? Nkarta was on my radar long before I joined—before it was even a company, in fact. In late 2014 or early 2015, I got a call from a friend, Simeon George, out of the blue. He said,…